AbbVie Inc.
ABBV
$211.96
-$6.08-2.79%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.05% | 5.45% | 3.71% | 0.72% | -1.83% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.05% | 5.45% | 3.71% | 0.72% | -1.83% |
| Cost of Revenue | 0.83% | -0.06% | 0.85% | -0.16% | -2.89% |
| Gross Profit | 8.35% | 7.91% | 4.99% | 1.09% | -1.35% |
| SG&A Expenses | 0.61% | 2.86% | 2.67% | 11.81% | 6.74% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -118.34% | -- | 30.00% | 193.89% | 193.89% |
| Total Operating Expenses | 3.15% | 4.19% | 4.32% | 7.40% | 3.59% |
| Operating Income | 12.31% | 8.13% | 2.46% | -11.70% | -11.77% |
| Income Before Tax | -57.12% | -51.90% | -40.54% | -10.07% | -32.38% |
| Income Tax Expenses | -143.18% | -138.07% | -141.39% | 39.27% | -2.39% |
| Earnings from Continuing Operations | -29.51% | -30.00% | -12.05% | -21.29% | -38.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 27.27% | 27.27% | 20.00% | -57.14% | -57.14% |
| Net Income | -29.52% | -30.00% | -12.03% | -21.37% | -38.53% |
| EBIT | 12.31% | 8.13% | 2.46% | -11.70% | -11.77% |
| EBITDA | 7.32% | 4.30% | 0.46% | -9.53% | -8.97% |
| EPS Basic | -29.71% | -30.18% | -12.09% | -21.38% | -38.53% |
| Normalized Basic EPS | 9.71% | 5.99% | 1.17% | -12.37% | -11.85% |
| EPS Diluted | -29.95% | -30.25% | -12.11% | -21.38% | -38.41% |
| Normalized Diluted EPS | 9.73% | 6.03% | 1.24% | -12.33% | -11.81% |
| Average Basic Shares Outstanding | -0.03% | -0.01% | -0.01% | -0.06% | -0.14% |
| Average Diluted Shares Outstanding | -0.04% | -0.04% | -0.07% | -0.11% | -0.20% |
| Dividend Per Share | 5.55% | 5.28% | 5.01% | 4.73% | 4.79% |
| Payout Ratio | 0.49% | 0.50% | 0.19% | 0.33% | 0.70% |